Publicaciones en colaboración con investigadores/as de Heinrich Heine University Düsseldorf (3)

2021

  1. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

    Leukemia, Vol. 35, Núm. 3, pp. 835-849

2017

  1. Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents

    Journal of Clinical Oncology, Vol. 35, Núm. 14, pp. 1591-1597

2016

  1. Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia

    European Journal of Haematology, Vol. 97, Núm. 1, pp. 33-38